FR2392987A1 - Ester tetra-nicotinique de papaveroline et procede d'obtention de ce produit actif contre les troubles circulatoires - Google Patents

Ester tetra-nicotinique de papaveroline et procede d'obtention de ce produit actif contre les troubles circulatoires

Info

Publication number
FR2392987A1
FR2392987A1 FR7816137A FR7816137A FR2392987A1 FR 2392987 A1 FR2392987 A1 FR 2392987A1 FR 7816137 A FR7816137 A FR 7816137A FR 7816137 A FR7816137 A FR 7816137A FR 2392987 A1 FR2392987 A1 FR 2392987A1
Authority
FR
France
Prior art keywords
papaveroline
tetra
obtaining
active product
circulatory disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7816137A
Other languages
English (en)
French (fr)
Other versions
FR2392987B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHARPER SpA
Original Assignee
SCHARPER SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHARPER SpA filed Critical SCHARPER SpA
Publication of FR2392987A1 publication Critical patent/FR2392987A1/fr
Application granted granted Critical
Publication of FR2392987B1 publication Critical patent/FR2392987B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7816137A 1977-05-30 1978-05-30 Ester tetra-nicotinique de papaveroline et procede d'obtention de ce produit actif contre les troubles circulatoires Granted FR2392987A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24141/77A IT1143667B (it) 1977-05-30 1977-05-30 Derivato paraverolinico ad azione duratura e procedimento per ottenerlo

Publications (2)

Publication Number Publication Date
FR2392987A1 true FR2392987A1 (fr) 1978-12-29
FR2392987B1 FR2392987B1 (de) 1982-04-23

Family

ID=11212187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7816137A Granted FR2392987A1 (fr) 1977-05-30 1978-05-30 Ester tetra-nicotinique de papaveroline et procede d'obtention de ce produit actif contre les troubles circulatoires

Country Status (13)

Country Link
JP (1) JPS53149982A (de)
BE (1) BE867515A (de)
BR (1) BR7803416A (de)
CA (1) CA1084504A (de)
CH (1) CH633446A5 (de)
DE (1) DE2822186A1 (de)
ES (1) ES470343A1 (de)
FR (1) FR2392987A1 (de)
GB (1) GB1593598A (de)
GR (1) GR63731B (de)
IT (1) IT1143667B (de)
MX (1) MX5515E (de)
PT (1) PT68115A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA803993B (en) * 1979-07-19 1981-07-29 Buzas Andre New isoquinoline derivatives and preparation thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR794M (de) * 1960-12-02 1961-09-11

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1175246B (de) * 1959-12-14 1964-08-06 Orsymonde Fa Verfahren zur Herstellung des Dimethylpapa-verolin-bis-nicotinsaeureesters und seines sauren Dimaleats

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR794M (de) * 1960-12-02 1961-09-11

Also Published As

Publication number Publication date
IT1143667B (it) 1986-10-22
BR7803416A (pt) 1979-01-02
JPS572715B2 (de) 1982-01-18
JPS53149982A (en) 1978-12-27
CA1084504A (en) 1980-08-26
MX5515E (es) 1983-09-14
BE867515A (fr) 1978-09-18
GR63731B (en) 1979-12-04
DE2822186A1 (de) 1978-12-14
CH633446A5 (en) 1982-12-15
ES470343A1 (es) 1979-01-01
PT68115A (en) 1978-06-01
FR2392987B1 (de) 1982-04-23
GB1593598A (en) 1981-07-22

Similar Documents

Publication Publication Date Title
DE69710204T2 (de) Alpha-amino sulfonyl hydroxamsäure als matrix metalloproteinase inhibitoren
AU603468B2 (en) Hydroxamic acid derivatives
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2530247A1 (fr) Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
US3047461A (en) Central nervous system stimulant
US4226861A (en) N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
JPS5925794B2 (ja) 尿素のヘテロシクリルカルボニル誘導体
EP0177960A2 (de) Tetrahydronaphtalinderivate, Verfahren und Zwischenprodukte zu deren Herstellung sowie diese enthaltende Arzneimittel
CA1089766A (fr) Application comme medicaments de derives du piperidyl- indole
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
CH644368A5 (en) Hydroxylated pyrimidine derivatives, their preparation and therapeutic composition containing them
DE3613573A1 (de) Cyclopentylether und ihre herstellung sowie pharmazeutische formulierung
FR2392987A1 (fr) Ester tetra-nicotinique de papaveroline et procede d'obtention de ce produit actif contre les troubles circulatoires
JPS6210235B2 (de)
FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
FR2371428A1 (fr) Stereo-isomeres du 1-(1'-benzyl-2'-pyrryl)-2-dibutyl sec.-amino-ethanol a activite analgesique et compositions pharmaceutiques qui les contiennent
EP0024030A1 (de) Pyrrolidin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4096247A (en) Gold thio glucopyranoside compounds and method of use
US4542141A (en) Compound having vasodilating, antiaggregating and hypocholesterolemic activities, process for the preparation thereof and pharmaceutical compositions therefrom
JPH02275846A (ja) カルボン酸誘導体
CH634297A5 (de) Prostaglandin-analoga.
EP0012801A1 (de) 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel
CA1060020A (fr) Procede de preparation de nouveaux derives de la dibenzo/b,c/ thiepine et leurs sels
EP0298818B1 (de) 1-Benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-Derivate, Verfahren zur Herstellung und Zwischenprodukte und Verwendung als Heilmittel
DE69025102T2 (de) 3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung

Legal Events

Date Code Title Description
ST Notification of lapse